Atea Pharmaceuticals, Inc. Common Stock AVIR
$5.12
-1.73%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-165,289,000
- Net Margin
- —
- Return on Equity
- -80.96%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.05
- Price / Sales
- —
Over the trailing twelve months, Atea Pharmaceuticals, Inc. Common Stock generated revenue of — and net income of $-165,289,000.
Key Stats
- Last Close
- $5.12
- Market Cap
- $417.87 million
- 52-Week Range
- $2.78 – $6.45
- Average Volume
- 264K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.